These findings suggest a mechanism where the sequestration of ERα by tau pathology might contribute to the loss of estrogen-mediated neuroprotection in AD, offering insights into gender differences in AD prevalence and progression [42]. This evidence concerns the gene ESR1 and Alzheimer disease.